1.
Ashutosh D. Wechalekar, Helen J. Lachmann, Mark Offer, Philip N. Hawkins, Julian D. Gillmore. Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease. haematol [Internet]. 2008Jan.31 [cited 2024Apr.30];93(2):295-8. Available from: https://haematologica.org/article/view/4754